Using High-technology to Enforce Low-technology Safety Measures: the Use of Third-party Remote Video Auditing and Real-time Feedback in Healthcare

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2011 Nov 24

PMID 22109950

Citations 51

Authors

Donna Armellino

Erfan Hussain

Mary Ellen Schilling

William Senicola

Ann Eichorn

Yosef Dlugacz

Bruce F Farber

Affiliations

Soon will be listed here.

Abstract

Background: Hand hygiene is a key measure in preventing infections. We evaluated healthcare worker (HCW) hand hygiene with the use of remote video auditing with and without feedback.

Methods: The study was conducted in an 17-bed intensive care unit from June 2008 through June 2010. We placed cameras with views of every sink and hand sanitizer dispenser to record hand hygiene of HCWs. Sensors in doorways identified when an individual(s) entered/exited. When video auditors observed a HCW performing hand hygiene upon entering/exiting, they assigned a pass; if not, a fail was assigned. Hand hygiene was measured during a 16-week period of remote video auditing without feedback and a 91-week period with feedback of data. Performance feedback was continuously displayed on electronic boards mounted within the hallways, and summary reports were delivered to supervisors by electronic mail.

Results: During the 16-week prefeedback period, hand hygiene rates were less than 10% (3933/60 542) and in the 16-week postfeedback period it was 81.6% (59 627/73 080). The increase was maintained through 75 weeks at 87.9% (262 826/298 860).

Conclusions: The data suggest that remote video auditing combined with feedback produced a significant and sustained improvement in hand hygiene.

Citing Articles

Video Documentation in Thyroidectomy and an Evaluation of Operative Notes.

Merdad M, Alsayid H, Alsharif S, Rammal A, Farsi N, Marzouki H Cureus. 2024; 16(7):e64446.

PMID: 39135830 PMC: 11317846. DOI: 10.7759/cureus.64446.

Healthcare Personnel Hand Hygiene Compliance: Are We There Yet?.

Armstrong-Novak J, Juan H, Cooper K, Bailey P Curr Infect Dis Rep. 2023; :1-7.

PMID: 37361491 PMC: 10213575. DOI: 10.1007/s11908-023-00806-8.

Implementation Strategies for Preventing Healthcare-Associated Infections across the Surgical Pathway: An Italian Multisociety Document.

Sartelli M, Bartoli S, Borghi F, Busani S, Carsetti A, Catena F Antibiotics (Basel). 2023; 12(3).

PMID: 36978388 PMC: 10044660. DOI: 10.3390/antibiotics12030521.

Evolution of the digital operating room: the place of video technology in surgery.

Cheikh Youssef S, Haram K, Noel J, Patel V, Porter J, Dasgupta P Langenbecks Arch Surg. 2023; 408(1):95.

PMID: 36807211 PMC: 9939374. DOI: 10.1007/s00423-023-02830-7.

Electronic monitoring of doffing using video surveillance to minimise error rate and increase safety at Howard Springs International Quarantine Facility.

Curtis S, Trewin A, McDermott K, Were K, Clezy K, Dempsey K Antimicrob Resist Infect Control. 2022; 11(1):120.

PMID: 36175981 PMC: 9522442. DOI: 10.1186/s13756-022-01155-2.

References

Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Picardi M . Mucormycosis in hematologic patients. Haematologica. 2004; 89(2):207-14. View

Wingard J, Carter S, Walsh T, Kurtzberg J, Small T, Baden L . Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 2010; 116(24):5111-8. PMC: 3012532. DOI: 10.1182/blood-2010-02-268151. View

Spellberg B, Ibrahim A, Chin-Hong P, Kontoyiannis D, Morris M, Perfect J . The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2011; 67(3):715-22. PMC: 3383100. DOI: 10.1093/jac/dkr375. View

Skiada A, Lanternier F, Groll A, Pagano L, Zimmerli S, Herbrecht R . Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica. 2012; 98(4):492-504. PMC: 3659979. DOI: 10.3324/haematol.2012.065110. View

Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F . Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009; 15(9):1395-401. PMC: 2819884. DOI: 10.3201/eid1509.090334. View

Pappas P, Alexander B, Andes D, Hadley S, Kauffman C, Freifeld A . Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50(8):1101-11. DOI: 10.1086/651262. View

Lanternier F, Lortholary O . Zygomycosis and diabetes mellitus. Clin Microbiol Infect. 2009; 15 Suppl 5:21-5. DOI: 10.1111/j.1469-0691.2009.02975.x. View

Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K . Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis. 2010; 16(9):1456-8. PMC: 3294978. DOI: 10.3201/eid1609.100276. View

Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L . Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect. 2012; 18(10):E396-400. DOI: 10.1111/j.1469-0691.2012.03908.x. View

10.

Husain S, Alexander B, Munoz P, Avery R, Houston S, Pruett T . Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003; 37(2):221-9. DOI: 10.1086/375822. View

11.

Skiada A, Pagano L, Groll A, Zimmerli S, DuPont B, Lagrou K . Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011; 17(12):1859-67. DOI: 10.1111/j.1469-0691.2010.03456.x. View

12.

Park B, Pappas P, Wannemuehler K, Alexander B, Anaissie E, Andes D . Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011; 17(10):1855-64. PMC: 3311117. DOI: 10.3201/eid1710.110087. View

13.

Marr K, Carter R, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34(7):909-17. DOI: 10.1086/339202. View

14.

Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M . Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients. Prog Transplant. 2008; 17(4):332-6. DOI: 10.1177/152692480701700412. View

15.

Kontoyiannis D, Lewis R . How I treat mucormycosis. Blood. 2011; 118(5):1216-24. PMC: 3292433. DOI: 10.1182/blood-2011-03-316430. View

16.

Einollahi B, Lessan-Pezeshki M, Pourfarziani V, Nemati E, Nafar M, Pour-Reza-Gholi F . Invasive fungal infections following renal transplantation: a review of 2410 recipients. Ann Transplant. 2008; 13(4):55-8. View

17.

Sun H, Aguado J, Bonatti H, Forrest G, Gupta K, Safdar N . Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009; 9(9):2166-71. DOI: 10.1111/j.1600-6143.2009.02754.x. View

18.

Ruping M, Heinz W, Kindo A, Rickerts V, Lass-Florl C, Beisel C . Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2009; 65(2):296-302. DOI: 10.1093/jac/dkp430. View

19.

Rammaert B, Lanternier F, Zahar J, Dannaoui E, Bougnoux M, Lecuit M . Healthcare-associated mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1:S44-54. DOI: 10.1093/cid/cir867. View

20.

Shoham S, Magill S, Merz W, Gonzalez C, Seibel N, Buchanan W . Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med Mycol. 2009; 48(3):511-7. DOI: 10.3109/13693780903311944. View